Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure
Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 1995-12, Vol.92 (11), p.3206-3211 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3211 |
---|---|
container_issue | 11 |
container_start_page | 3206 |
container_title | Circulation (New York, N.Y.) |
container_volume | 92 |
creator | GRASSI, G SERAVALLE, G MANCIA, G CATTANEO, B. M LANFRANCHI, A VAILATI, S GIANNATTASIO, C DEL BO, A SALA, C BOLLA, G. B POZZI, M |
description | Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF.
We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was < 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P < .05 and P < .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups.
These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF. |
doi_str_mv | 10.1161/01.cir.92.11.3206 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77705042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24844004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</originalsourceid><addsrcrecordid>eNpdkEtLLDEUhIMoOlf9AS6EIOKux7zTWcqg3gFB8LE1xPRpjaS7x6Rb9N-bwUEudxWK-qo4KYSOKJlTqug5oXMf0tywIuecEbWFZlQyUQnJzTaaEUJMpTlje-hPzm9FKq7lLtrVslacyBl6uv_qVm58hTF47PwYPtwYhh67vsFxyBkPLU7QRvjE-R_SD_2YhohDj7sQm7V-gVzSgF_BpRG3LsQpwQHaaV3McLh599Hj1eXD4m91c3u9XFzcVF6SeqxU65gERZ6NAmYa3RDNhRBApQKuldLgRUs81FyD40IZTorNWq1cY0xt-D46--ldpeF9KpfYLmQPMboehilbrTWRRLACnvwHvg1T6sttllGmeG20LhD9gXwqE5Tv21UKnUtflhK7Ht4SahfLO2tYkXY9fMkcb4qn5w6a38Rm6eKfbnyXvYttcr0P-RdjhorSwr8Bs9aLFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212638977</pqid></control><display><type>article</type><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</creator><creatorcontrib>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</creatorcontrib><description>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF.
We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was < 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P < .05 and P < .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups.
These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.cir.92.11.3206</identifier><identifier>PMID: 7586305</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Aged ; Baroreflex - physiology ; Biological and medical sciences ; Blood Pressure - physiology ; Cardiology. Vascular system ; Case-Control Studies ; Cold Temperature ; Female ; Heart ; Heart Failure - diagnosis ; Heart Failure - physiopathology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Rate - physiology ; Humans ; Male ; Medical sciences ; Middle Aged ; Nitroprusside ; Norepinephrine - blood ; Phenylephrine ; Pressoreceptors - drug effects ; Pressoreceptors - physiopathology ; Sympathetic Nervous System - physiopathology ; Vasoconstrictor Agents ; Vasodilator Agents</subject><ispartof>Circulation (New York, N.Y.), 1995-12, Vol.92 (11), p.3206-3211</ispartof><rights>1996 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Dec 1, 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</citedby><cites>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2914063$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7586305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GRASSI, G</creatorcontrib><creatorcontrib>SERAVALLE, G</creatorcontrib><creatorcontrib>MANCIA, G</creatorcontrib><creatorcontrib>CATTANEO, B. M</creatorcontrib><creatorcontrib>LANFRANCHI, A</creatorcontrib><creatorcontrib>VAILATI, S</creatorcontrib><creatorcontrib>GIANNATTASIO, C</creatorcontrib><creatorcontrib>DEL BO, A</creatorcontrib><creatorcontrib>SALA, C</creatorcontrib><creatorcontrib>BOLLA, G. B</creatorcontrib><creatorcontrib>POZZI, M</creatorcontrib><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF.
We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was < 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P < .05 and P < .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups.
These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</description><subject>Adult</subject><subject>Aged</subject><subject>Baroreflex - physiology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - physiology</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Cold Temperature</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - physiopathology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Rate - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitroprusside</subject><subject>Norepinephrine - blood</subject><subject>Phenylephrine</subject><subject>Pressoreceptors - drug effects</subject><subject>Pressoreceptors - physiopathology</subject><subject>Sympathetic Nervous System - physiopathology</subject><subject>Vasoconstrictor Agents</subject><subject>Vasodilator Agents</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLLDEUhIMoOlf9AS6EIOKux7zTWcqg3gFB8LE1xPRpjaS7x6Rb9N-bwUEudxWK-qo4KYSOKJlTqug5oXMf0tywIuecEbWFZlQyUQnJzTaaEUJMpTlje-hPzm9FKq7lLtrVslacyBl6uv_qVm58hTF47PwYPtwYhh67vsFxyBkPLU7QRvjE-R_SD_2YhohDj7sQm7V-gVzSgF_BpRG3LsQpwQHaaV3McLh599Hj1eXD4m91c3u9XFzcVF6SeqxU65gERZ6NAmYa3RDNhRBApQKuldLgRUs81FyD40IZTorNWq1cY0xt-D46--ldpeF9KpfYLmQPMboehilbrTWRRLACnvwHvg1T6sttllGmeG20LhD9gXwqE5Tv21UKnUtflhK7Ht4SahfLO2tYkXY9fMkcb4qn5w6a38Rm6eKfbnyXvYttcr0P-RdjhorSwr8Bs9aLFg</recordid><startdate>19951201</startdate><enddate>19951201</enddate><creator>GRASSI, G</creator><creator>SERAVALLE, G</creator><creator>MANCIA, G</creator><creator>CATTANEO, B. M</creator><creator>LANFRANCHI, A</creator><creator>VAILATI, S</creator><creator>GIANNATTASIO, C</creator><creator>DEL BO, A</creator><creator>SALA, C</creator><creator>BOLLA, G. B</creator><creator>POZZI, M</creator><general>Lippincott Williams & Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19951201</creationdate><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><author>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Baroreflex - physiology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - physiology</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Cold Temperature</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - physiopathology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Rate - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitroprusside</topic><topic>Norepinephrine - blood</topic><topic>Phenylephrine</topic><topic>Pressoreceptors - drug effects</topic><topic>Pressoreceptors - physiopathology</topic><topic>Sympathetic Nervous System - physiopathology</topic><topic>Vasoconstrictor Agents</topic><topic>Vasodilator Agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GRASSI, G</creatorcontrib><creatorcontrib>SERAVALLE, G</creatorcontrib><creatorcontrib>MANCIA, G</creatorcontrib><creatorcontrib>CATTANEO, B. M</creatorcontrib><creatorcontrib>LANFRANCHI, A</creatorcontrib><creatorcontrib>VAILATI, S</creatorcontrib><creatorcontrib>GIANNATTASIO, C</creatorcontrib><creatorcontrib>DEL BO, A</creatorcontrib><creatorcontrib>SALA, C</creatorcontrib><creatorcontrib>BOLLA, G. B</creatorcontrib><creatorcontrib>POZZI, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GRASSI, G</au><au>SERAVALLE, G</au><au>MANCIA, G</au><au>CATTANEO, B. M</au><au>LANFRANCHI, A</au><au>VAILATI, S</au><au>GIANNATTASIO, C</au><au>DEL BO, A</au><au>SALA, C</au><au>BOLLA, G. B</au><au>POZZI, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1995-12-01</date><risdate>1995</risdate><volume>92</volume><issue>11</issue><spage>3206</spage><epage>3211</epage><pages>3206-3211</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF.
We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was < 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P < .05 and P < .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups.
These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>7586305</pmid><doi>10.1161/01.cir.92.11.3206</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 1995-12, Vol.92 (11), p.3206-3211 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_proquest_miscellaneous_77705042 |
source | MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete |
subjects | Adult Aged Baroreflex - physiology Biological and medical sciences Blood Pressure - physiology Cardiology. Vascular system Case-Control Studies Cold Temperature Female Heart Heart Failure - diagnosis Heart Failure - physiopathology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Rate - physiology Humans Male Medical sciences Middle Aged Nitroprusside Norepinephrine - blood Phenylephrine Pressoreceptors - drug effects Pressoreceptors - physiopathology Sympathetic Nervous System - physiopathology Vasoconstrictor Agents Vasodilator Agents |
title | Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A03%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sympathetic%20activation%20and%20loss%20of%20reflex%20sympathetic%20control%20in%20mild%20congestive%20heart%20failure&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=GRASSI,%20G&rft.date=1995-12-01&rft.volume=92&rft.issue=11&rft.spage=3206&rft.epage=3211&rft.pages=3206-3211&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.cir.92.11.3206&rft_dat=%3Cproquest_cross%3E24844004%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212638977&rft_id=info:pmid/7586305&rfr_iscdi=true |